-

Rockwell Medical to Release Third Quarter 2022 Financial Results on Monday, November 14

WIXOM, Mich.--(BUSINESS WIRE)--Rockwell Medical, Inc. (Nasdaq:RMTI), a commercial healthcare company focused on providing life-sustaining products for patients suffering from blood disorders and diseases associated with the kidney, today announced that it will release its financial results for the third quarter ended September 30, 2022 on Monday, November 14, 2022. The Company will issue a press release at 6:00am ET followed by a live conference call and webcast at 8:00am ET.

CONFERENCE CALL AND WEBCAST DETAILS
Please call 10 minutes prior to the call to register.

Date: Monday, November 14, 2022

Time: 8:00am ET

Webcast: www.RockwellMed.com/Results

Live Number: (888) 660-6347 // (International) 1 (929) 201-6594

Replay Number: (800) 770-2030 // (International) 1 (647) 362-9199
A replay will be available via the replay number and webcast through December 14, 2022.

Access Code: 4944610

Speakers: Mark Strobeck, Ph.D., President and Chief Executive Officer; and Russell Skibsted, Chief Financial Officer and Chief Business Officer

Format: Discussion of third quarter 2022 operational and financial results followed by Q&A.

About Rockwell Medical
Rockwell Medical is a commercial healthcare company focused on providing life-sustaining products for patients suffering from blood disorders and diseases associated with the kidney. For more information, visit www.RockwellMed.com.

Contacts

Heather R. Hunter
SVP, Chief Corporate Affairs Offier
(248) 432-1362
IR@RockwellMed.com

Rockwell Medical, Inc.

NASDAQ:RMTI
Details
Headquarters: Wixom, MI
CEO: Mark Strobeck
Employees: 250
Organization: PUB
Revenues: 83,600,000 (2023)

Release Versions
$Cashtags

Contacts

Heather R. Hunter
SVP, Chief Corporate Affairs Offier
(248) 432-1362
IR@RockwellMed.com

Social Media Profiles
More News From Rockwell Medical, Inc.

Rockwell Medical Announces 1-for-10 Reverse Stock Split

WIXOM, Mich.--(BUSINESS WIRE)--Rockwell Medical's Board of Directors has authorized a 1-for-10 reverse split of the Company's issued and outstanding common stock....

Rockwell Medical Renews Product Purchase Agreement with aQua Dialysis

WIXOM, Mich.--(BUSINESS WIRE)--Rockwell Medical will supply aQua Dialysis with liquid and dry, acid and bicarbonate hemodialysis concentrates and other essential dialysis products....

Rockwell Medical Signs New 3-Year Product Purchase Agreement with Heritage Dialysis

WIXOM, Mich.--(BUSINESS WIRE)--Rockwell Medical will supply Heritage Dialysis with a portfolio of hemodialysis products including PureCart, RenalPure, SteriLyte and other products....
Back to Newsroom